Table 1 The results of COX regression analysis based on TCGA-glioma dataset

TOP2A

Low

Reference

Reference

High

4.080 (3.076–5.411)

1.970 (1.041–3.730)

SMO

Low

Reference

Reference

High

3.412 (2.614–4.454)

1.582 (1.113–2.247)

CASP6

Low

Reference

Reference

High

5.963 (4.459–7.975)

1.713 (1.043–2.813)

PSMB9

Low

Reference

Reference

High

4.487 (3.416–5.895)

1.678 (1.161–2.426)

GRIN1

Low

Reference

Reference

High

0.362 (0.280–0.468)

0.619 (0.398–0.963)

MCL1

Low

Reference

Reference

High

1.871 (1.465–2.388)

1.467 (1.070–2.012)

BCHE

Low

Reference

Reference

High

0.588 (0.462–0.750)

0.716 (0.532–0.964)

CA12

Low

Reference

Reference

High

2.586 (2.013–3.323)

1.821 (1.350–2.456)

NTRK3

Low

Reference

Reference

High

0.383 (0.295–0.496)

0.651 (0.474–0.895)

AURKB

Low

Reference

Reference

High

4.446 (3.355–5.891)

1.766 (1.022–3.053)

CA3

Low

Reference

Reference

High

5.008 (3.791–6.615)

1.521 (1.044–2.214)

PTGS1

Low

Reference

Reference

High

2.998 (2.309–3.891)

1.704 (1.085–2.678)

ADORA1

Low

Reference

Reference

High

2.127 (1.665–2.717)

1.387 (1.021–1.884)

MGMT

Low

Reference

Reference

High

1.775 (1.392–2.264)

1.522 (1.158–2.000)

NFE2L2

Low

Reference

Reference

High

2.247 (1.748–2.890)

2.153 (1.532–3.027)

AVPR1B

Low

Reference

Reference

High

1.273 (1.002–1.617)

1.471 (1.133–1.909)